Clinical trial · Interventional
Ultrasound Elastography in Diagnosing Patients With Kidney or Liver Solid Focal Lesions
US Elastography for Characterizing Focal Lesions in the Liver and Kidney
NCT01908166CI-TRIAL-00028035completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This clinical trial studies ultrasound elastography in diagnosing patients with kidney or liver solid focal lesions. New diagnostic procedures, such as ultrasound elastography, may be a less invasive way to check for kidney or liver solid focal lesions.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Adult Primary Liver Cancer | — | UNRESOLVED | — |
| Kidney Tumor | Kidney Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| ultrasound elasticity imaging | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Diagnostic (ultrasound elastography)
- description
- Patients undergo ultrasound elastography.
- interventionNames
- Procedure: ultrasound elasticity imaging
Primary outcomes (1)
- measure
- Strain ratio for all lesions measured by comparing the lesion to the adjacent normal tissue
- timeFrame
- Up to 36 months
- description
- Suspicious liver and kidney lesions will be analyzed separately on a per-lesion basis. Within each population, the strain ratio of cases and controls will be compared using the Wilcoxon rank sum test, and the analysis will be illustrated using the non-parametric receiver operating characteristic (ROC).
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 19 Years
Show eligibility criteria text
Inclusion Criteria: * There are no restrictions on life expectancy * Eastern Cooperative Oncology Group (ECOG) or Karnofsky performance status will not be employed * Patients of any ethnic background * Ability to understand and the willingness to sign a written informed consent document Exclusion Criteria: * Patients should not be taking other investigational agents * No requirements due to co-morbid disease or intercurrent illness, as needed * No restrictions on allergic reactions as no imaging agent will be used * Concomitant medications for treatment of the target lesion * Pregnant or nursing patients will be excluded from the study
References
Publications (0)
Data not yet available
No reference posted for this study.